Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM, Cardona K, Koseła-Paterczyk H, Rutkowski P.
Surg Oncol Clin N Am. 2022 Jul;31(3):419-430. doi: 10.1016/j.soc.2022.03.006.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S.
Lancet Oncol. 2017 Nov;18(11):1493-1501. doi: 10.1016/S1470-2045(17)30624-1. Epub 2017 Oct 4.
Cytology of Undifferentiated Round-Cell Sarcomas of Bone and Soft Tissue: Ewing Sarcoma or Not Ewing Sarcoma, That Is the Question.
Gajdzis P, Pierron G, Klijanienko J.
Acta Cytol. 2022;66(4):295-306. doi: 10.1159/000518146. Epub 2021 Aug 25.
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.
Sbaraglia M, Bellan E, Dei Tos AP.
Pathologica. 2021 Apr;113(2):70-84. doi: 10.32074/1591-951X-213. Epub 2020 Nov 3.
Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
Ali NM, Niada S, Brini AT, Morris MR, Kurusamy S, Alholle A, Huen D, Antonescu CR, Tirode F, Sumathi V, Latif F.
J Pathol. 2019 Feb;247(2):166-176. doi: 10.1002/path.5176. Epub 2018 Dec 27.
Comparison of Features and Outcomes of Undifferentiated Pleomorphic Sarcoma of Bone and Soft Tissue.
Gusho CA, Lee L, Guntin J, Blank AT.
J Surg Res. 2022 Feb;270:313-320. doi: 10.1016/j.jss.2021.09.032. Epub 2021 Oct 29.
Clinical characteristics of undifferentiated pleomorphic sarcoma of bone and the impact of adjuvant chemotherapy on the affected patients: a population-based cohort study.
Kobayashi H, Zhang L, Hirai T, Tsuda Y, Ikegami M, Tanaka S.
Jpn J Clin Oncol. 2022 May 31;52(6):589-598. doi: 10.1093/jjco/hyac017.
Ewing sarcoma and Ewing-like tumors.
Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP.
Virchows Arch. 2020 Jan;476(1):109-119. doi: 10.1007/s00428-019-02720-8. Epub 2019 Dec 4.
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Movva S, Seier K, Avutu V, Banks LB, Chan J, Chi P, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Maki R, Rosenbaum E, Salcito T, Rodriguez K, Dempsey R, Meyers PA, Cohen SM, Hensley ML, Konner JA, Schram AM, Lefkowitz RA, Erinjeri JP, Qin LX, Tap WD, D'Angelo SP.
Clin Cancer Res. 2024 Dec 16;30(24):5612-5619. doi: 10.1158/1078-0432.CCR-24-2519.
Imaging of bone and soft tissue BCOR-rearranged sarcoma.
Sirisena UDN, Rajakulasingam R, Saifuddin A.
Skeletal Radiol. 2021 Jul;50(7):1291-1301. doi: 10.1007/s00256-020-03683-7. Epub 2021 Jan 2.
